1. A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT‐R study. Issue 12 (16th August 2018) Authors: Scott, Russell; Morgan, Jerry; Zimmer, Zachary; Lam, Raymond L. H.; O'Neill, Edward A.; Kaufman, Keith D.; Engel, Samuel S.; Raji, Annaswamy Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 12(2018) Page Start: 2876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗